Company overview
Basic information
Company name
Shapropharma, UAB
Company code
306379268
VAT code
LT100016251018
Registered address
Klaipėda, Sandėlių g. 30, LT-95107
Registration date
2023-08-14
Company age: 3 y. 1 mo.
Contact information
Edit data
Phone
Email
Not disclosed
(personal)
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Private Limited Liability Company
NACE activity
Retail sale of pharmaceutical products
Ownership form
Private without foreign capital
UAB Shapropharma
Company code: 306379268
Address: Klaipėda, Sandėlių g. 30, LT-95107
VAT code: LT100016251018
Download a detailed company report
Make confident decisions with all the information about Shapropharma, UAB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.
Description
This description was generated by artificial intelligence.
Shapropharma, UAB (company code 306379268) is a private limited liability company registered on 14 August 2023 and currently operational. It is a privately owned micro company with governance described as CEO only, and it belongs to the sector of national private non-financial companies. The company is based in Klaipeda, Klaipedos city municipality, Klaipedos County, at Sandeliu g. 30. Its registered activity is retail sale of pharmaceutical products (EVRK code G.47.73.00). The share capital is EUR 1.0K.
The latest available financial figures are for 2024, when the company generated EUR 37.5K in revenue and recorded a net loss of EUR 1.5K, corresponding to a profit margin of -3.9%. At the end of 2024, equity remained negative at EUR 3.0K, liabilities stood at EUR 41.4K, and total assets were EUR 38.2K. In 2023, during a 139-day period after registration, the company also reported a net loss. Staff levels have remained stable at 1 employee on average, and so far in 2026 the company has continued to employ 1 person on average.
The latest available financial figures are for 2024, when the company generated EUR 37.5K in revenue and recorded a net loss of EUR 1.5K, corresponding to a profit margin of -3.9%. At the end of 2024, equity remained negative at EUR 3.0K, liabilities stood at EUR 41.4K, and total assets were EUR 38.2K. In 2023, during a 139-day period after registration, the company also reported a net loss. Staff levels have remained stable at 1 employee on average, and so far in 2026 the company has continued to employ 1 person on average.